Biosimilars

The Pharmacy Times® Biosimilars Resource Center is a comprehensive resource for clinical news and expert insights on issues related to biosimilar drugs, a biological product that is highly similar to a reference biologic for which there are no clinically meaningful differences in terms of safety, purity, and efficacy.

Latest News

Integrating Biosimilars Into Retina and Neurology Practices Requires Careful Planning
Integrating Biosimilars Into Retina and Neurology Practices Requires Careful Planning

January 14th 2025

Successfully integrating biosimilars into practices requires careful planning and execution, as they impact virtually all aspects of a practice.

Doctor with human Liver anatomy model. Liver cancer and Tumor, Jaundice, Viral Hepatitis A, B, C, D, E, Cirrhosis, Failure, Enlarged, Hepatic Encephalopathy, Ascites Fluid in Belly and health concept - Image credit: Jo Panuwat D | stock.adobe.com
Phase 2 Study Evaluates Serplulimab Plus HLX04 as First-Line Treatment for Advanced Hepatocellular Carcinoma

January 9th 2025

Optimizing Inflammatory Bowel Disease Management: The Value of Integrated Pharmacists in Modern Health Care
Optimizing Inflammatory Bowel Disease Management: The Value of Integrated Pharmacists in Modern Health Care

January 3rd 2025

fda approved label. fda approved red band sign. fda approved - Image credit: Aquir | stock.adobe.com
Ustekinumab-stba Receives FDA Approval for Autoimmune Disorder and Inflammatory Bowel Disease

December 18th 2024

Biosimilars, Digital Tool, Patients, Health Care Professionals, Education | Image Credit: © Pixels Hunter | stock.adobe.com
Investigators Develop Training Tool to Improve Prescriber-Patient Communication About Biosimilars

December 17th 2024

<1
...
1516171819